Pralatrexate (Folotyn) for Peripheral T-Cell Lymphoma

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2010年 / 52卷 / 1342期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：55 / 56
页数：2
相关论文
共 50 条
  • [1] The potential of pralatrexate as a treatment of peripheral T-cell lymphoma
    Dondi, Alessandra
    Bari, Alessia
    Pozzi, Samantha
    Ferri, Paola
    Sacchi, Stefano
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 711 - 718
  • [2] Current and Emerging Therapies in Peripheral T-cell Lymphoma: Focus on Pralatrexate
    Reungwetwattana, Thanyanan
    Jaramillo, Sylvia
    Molina, Julian R.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 125 - 135
  • [3] Cutaneous Toxicity Associated with Pralatrexate in Cutaneous and Peripheral T-Cell Lymphoma
    Parker, Terri L.
    Barbarotta, Lisa
    Girardi, Michael
    Foss, Francine M.
    BLOOD, 2012, 120 (21)
  • [4] Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma
    Rodd, Annabelle L.
    Ververis, Katherine
    Karagiannis, Tom C.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 305 - 314
  • [5] Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary
    Malik, Shakun M.
    Liu, Ke
    Qiang, Xu
    Sridhara, Rajeshwari
    Tang, Shenghui
    McGuinn, W. David, Jr.
    Verbois, S. Leigh
    Marathe, Anshu
    Williams, Gene M.
    Bullock, Julie
    Tornoe, Christoffer
    Lin, Sue Ching
    Ocheltree, Terrance
    Vialpando, Milinda
    Kacuba, Alice
    Justice, Robert
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2010, 16 (20) : 4921 - 4927
  • [6] Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma
    Bhangoo, Ronik S.
    Bhangoo, Munveer S.
    Mangold, Aaron R.
    Wong, William W.
    ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (01) : 31 - 34
  • [7] Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Jennifer, Zhao C.
    Sara Mohamed, Jaszczur
    Salma, Afifi
    Francine, Foss
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (06) : 577 - 583
  • [8] Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate*
    Foss, Francine M.
    Parker, Terri L.
    Girardi, Michael
    Li, Anlong
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2927 - 2930
  • [9] Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Marchi, Enrica
    O'Connor, Owen A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (04) : 227 - 235
  • [10] PRALATREXATE IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA; REPORT ON THREE PATIENTS
    Tezel, Pinar
    Bulbul, Hale
    Koseoglu, Fatos Dilan
    Davulcu, Eren Arslan
    Ulusoy, Yusuf
    Soyer, Nur Akad
    Sahin, Fahri
    Tombuloglu, Murat
    Saydam, Guray
    LEUKEMIA RESEARCH, 2017, 61 : S51 - S51
12345